Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

Alza and SmithKline Beecham sign new agreement for Nicoderm

April 22, 1997

Ibogamine congeners for addiction

April 15, 1997

Allelix and Pharm-Eco create partnership

April 10, 1997

PDL and Teijin agreement for MAb to E. coli toxin

April 9, 1997

Genes involved in marijuana abuse

April 8, 1997

Pharmacia & Upjohn purchases U.S. manufacturing rights for Cygnus' Nicotrol

March 10, 1997

Selective nAChR ligands prepared by Novo Nordisk

Feb. 27, 1997

Sano begins pivotal trials with smoking cessation product

Feb. 26, 1997

Allelix and Pharm-Eco form joint venture

Jan. 27, 1997

NIH seeks licensees for dopamine reuptake inhibitors

Jan. 23, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...